top of page

About Us

Anchor 1

Meet The Team

YC Headshot2022.jpg

Yann Chong TAN, PhD

Co-Founder and CEO

Co-founded multiple biotech companies which collectively raised more than $400M in funding with successful IPO exit, in which he held various C-suite roles including that of Chief Scientific Officer.

John Lee.jpeg

John LEE, MD PhD

Chief Medical Officer

Board-certified cardiologist with extensive clinical development expertise in both pharma and biotech companies and led clinical development programs of a public biotech from Phase I-III

OhDearStudio_ Nuevocor_071_edited_edited.jpg

Cheryl LEE

Vice President, Operations

Experienced life science operator and finance leader with more than 15 years of operational experience

Christian Beck.jpeg

Christian BECK, PhD

Vice President, Corporate Development

Unique experience in corporate finance, strategy and business development with biopharma transaction experience gained at global investment banks and a biopharma company.

Khoo Shih_Portrait_JO1_8043-retouched_WEBRES_edited.jpg

KHOO Shih, PhD

Board Member

Seasoned investor with more than 15 years of experience investing in private and public life sciences and healthcare companies globally.

CEO, ClavystBio

Mia Hu.jpg

Mia HU, PhD

Board Member

Healthcare investor with global investing and incubator expertise

Investment Director at Boehringer Ingelheim Venture Fund

WhatsApp Image 2021-05-25 at 10.40.54 AM

Brian BURKE, PhD

Co-Founder and Scientific Advisor

Distinguished cell biologist in the area of the nuclear envelope, including lamins and the LINC complex, through the innovative use of microscopic and biochemical technologies.

Former Research Director at the Agency for Science, Technology and Research, Singapore

James Nelson website_edited.jpg


Scientific Advisor

Eminent cell biologist with seminal contributions in mechanobiology, membrane trafficking and cellular organization.

Professor Emeritus at Stanford University 

WhatsApp Image 2021-05-25 at 11.10.03 AM


Co-Founder and Scientific Advisor

Pioneer in techniques underpinning mouse experimental genetics, and developer of multiple mouse models for laminopathies for elucidating mechanisms of disease.

Former Research Director at the Agency for Science, Technology and Research, Singapore


Mark KAY, MD, PhD

Co-Founder and Scientific Advisor

World expert in the area of gene therapy technologies for the treatment of genetic and acquired diseases, including the discovery of novel adeno-associated virus (AAV) capsids.

Head of the Division of Human Gene Therapy; and Professor of Pediatrics and Genetics at Stanford University

bottom of page